Patent · US Active

Biomarkers for seizures

US9983219B2 · kind B2 · utility

1Cited by
6References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 16, 2017
Grant dateMay 29, 2018
Priority date
Expiry dateAug 16, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2857
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The application relates to markers for seizures and epilepsy. Polypeptide expression panels or arrays are provided, comprising one or more probes capable of binding specific polypeptides in blood plasma or blood serum of a mammalian subject. Also provided are methods for detecting seizure, methods for predicting seizure, use of sICAM-5 in the treatment of seizure, methods for assessing the effectiveness of a treatment of seizure, and diagnostic kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.